News Recovering from coronavirus with type 1 diabetes
A man with type 1 diabetes who is recovering from coronavirus has shared his experience, explaining that for him, the condition was “no different to normal flu-type symptoms”. Andrew O’Dwyer developed the condition after he flew to Italy in February for a skiing trip. Speaking to BBC News, he said:…
A fifth of people with type 1 diabetes may have additional autoimmune disease
medwireNews: People with type 1 diabetes should be screened for other autoimmune diseases, a Finnish research team suggests, after finding these individuals particularly vulnerable to additional disorders. The study of more than 4000 Finnish individuals with type 1 diabetes revealed that 22.8% had at least one additional autoimmune disease, with…
Health Canada approves fast-acting mealtime insulin, Fiasp®, for children with diabetes
Novo Nordisk Canada Inc. Mar 09, 2020, 08:01 ET Health Canada also expands Fiasp® approval to include insulin infusion pumps MISSISSAUGA, ON, March 9, 2020 /CNW/ – Fiasp® (insulin aspart injection), a faster acting mealtime insulin, is now approved in Canada for pediatric patients aged 2 years and above giving Canadian families…
Study: Rotavirus Vaccination Not Associated with Type 1 Diabetes in Children
2020-03-09 21:15:00 Jill Murphy, Assistant Editor A recent study conducted by JAMA Pediatrics found that the rotavirus vaccination does not appear to be associated with type 1 diabetes in children. Rotovirus infection is a hypothesized risk factor for type 1 diabetes, according to the authors. The objective of the study…
Finance Committee’s Budget Recommendations Positive for Canadians with Diabetes
TORONTO, March 03, 2020 (GLOBE NEWSWIRE) — JDRF Canada, the leading global funder of type 1 diabetes (T1D) research, welcomes the release of the Standing Committee on Finance’s report and its recommendations to address the diabetes epidemic. We particularly welcome its recommendation that the government support the development of a…
Full interview: Genprex’s newly licensed type 1 diabetes gene therapy’s potential explained by scientist
Dr George Gittes, Professor of Surgery at the Children’s Hospital of Pittsburgh explains how and why he began working on the gene therapy licensed by Genprex (NASDAQ:GNPX). Dr Gittes says the therapy, currently undergoing pre-clinical studies, has shown data where it caused pancreatic cells to turn into insulin-producing cells. Watch…
Why are some people at greater risk from coronavirus?
People with diabetes or heart disease are known to be more at risk from coronavirus, which is starting to spread rapidly in the UK and internationally. That is a concern for the 7.4 million Britons who have some form of cardiac or circulatory disease, which includes 4.8 million people with…
Breakthrough Research Cures Diabetes Type 1 Using Stem Cells
New research, which was led by the assistant professor of medicine and biomedical engineering at Washington University School of Medicine in St. Louis, Jeffrey R. Millman, has recently shown the potential of stem cells in the treatment of type 1 diabetes. More specifically, the researchers looked at how stem cells…
Do Pancreatic Cells Write Their Own Autoimmune Ending?
Do the insulin-producing beta cells in the pancreas unwittingly produce a signal that aids their own demise in Type 1 diabetes? That appears to be the case, according to lipid signaling research co-led by Sasanka Ramanadham, Ph.D., professor of cell, developmental and integrative biology at the University of Alabama at…
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results Boston, MA — Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had…
